MedTrace Logo

Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception

NCT03077555 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2018-03-23

No results posted yet for this study

Summary

Quick starting combined oral contraception containing estradiol hemihydrate/nomegestrol acetate is effective to inhibit ovulation in healthy reproductive age women and non-inferiority to combined oral contraception containing ethinyl estradiol/gestodene.

Conditions

  • Ovulation Inhibition

Interventions

DRUG

Zoely

quick start of combined hormonal contraception containing 1.5 mg estradiol /2.5 mg nomegestrol acetate

DRUG

Meliane ED

quick start of combined hormonal contraception containing 20 mcg ethinyl estradiol /75 mcg gestodene

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-21
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077555 on ClinicalTrials.gov